1. 1. Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390: 2461-2471, 2017.
2. 2. Turkoz FP, Solak M, Kilickap S, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer 14: 164-172, 2014.
3. 3. Pallini R, Sabatino G, Doglietto F, Lauretti L, Fernandez E, Maira G. Clivus metastases: report of seven patients and literature review. Acta Neurochir (Wien) 151: 291-296; discussion 296, 2009.
4. 4. Dekker SE, Wasman J, Yoo KK, et al. Clival metastasis of a duodenal adenocarcinoma: a case report and literature review. World Neurosurg 100: 62-68, 2017.
5. 5. Fukushima M, Katayama Y, Shigemori Y, Miyake H, Hirayama T, Kotani A. Clivus metastasis from gastric signet ring cell carcinoma after a 10-year disease-free interval-case report. Neurol Med Chir (Tokyo) 52: 751-753, 2012.